In DLBCL, the expression of CEBPA, BBC3, GALR3, BMP8B, and BAALC was markedly higher than in the control group (P< 0.05) (Figures 7A–E). The gene discussed is CEBPA; the disease is diffuse large B-cell lymphoma.